VIDEO ACCESS:

RELEASE: September 14, 2016
EXPIRATION: December 31, 2017 (Credit is not available after this expiration date)

PRESENTER: Mark Frye, M.D.
TITLE:  Pharmacogenomic Targets in Mood Disorders

LEARNING OBJECTIVES

  • Review pharmacokinetic genetic variation of psychotropic drugs
  • Review the impact of genetic variation on pharmacogenmoic drug response or adverse event
  • Translate how these research advances may impact practice

ACCREDITATION:

Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Mayo Clinic College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensuracte with the extent of their participation in the activity.

INSTRUCTIONS:

  • Select the Take Course button below.
  • Participate in the quiz.  Participants must pass by a minimum of 80%, 1 re-take is allowed.  Quizzes will have between 2-5 questions.
  • Complete the evaluation.

TRANSCRIPT:
This credit will appear on your Transcript for permanent record.  To access your transcript, visit My Account, My Activities, Transcript

DISCLOSURE SUMMARY:
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of Continuous Professional Development), must ensure balance, independence, objectivity and scientific rigor in its educational activities.   Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry: 

Speaker:  Mark A. Frye, M.D.

Grant Support:  AssureRx, Janssen Research & Development, Mayo Foundation, Myriad, National Institute of Alcohol Abuse and Alcoholism (NIAAA), National Institute of Mental Health (NIMH), Pfizer

Consultant (Mayo):   Janssen Research & Development, LLC, Mitsubishi Tanabe Pharma Corporation, Myriad Genetics, Sunovion, Supernus Pharmaceuticals, Teva Pharmaceuticals, Neuralstem, Inc.

CME/Travel Support:  American Physician Institute, CME Outfitters 

No relevant financial relationship(s) with industry:
Brian Palmer, M.D., Michael Bostwick, M.D., Karen Grothe, Ph.D., Lois Krahn, M.D., Jarrod Leffler, Ph.D., Larissa Loukianova, M.D., Mary Machulda, M.D., Patricia Maus, M.D., Amber Pearson, Jeffrey Staab, M.D., Cosima Swintak, M.D., Kristin Vickers Douglas, Ph.D., Cynthia Harbeck-Weber, Ph.D., Michael Zaccariello, Ph.D. - SPEAKER: Daniel Hall-Flavin, MD

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:  None

QUESTIONS?
MAYO STAFF: Contact rstpsychgr@mayo.edu
MAYO CLINIC CARE NETWORK MEMBERS:  Contact cme@mayo.edu 

Presenter: 
Mark Frye, MD
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota